13,363 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Bought by Stephens Inc. AR

Stephens Inc. AR bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,363 shares of the company's stock, valued at approximately $300,000.

A number of other institutional investors have also added to or reduced their stakes in PRVA. Durable Capital Partners LP increased its holdings in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock valued at $224,587,000 after purchasing an additional 378,255 shares during the last quarter. Nuveen Asset Management LLC increased its holdings in shares of Privia Health Group by 19.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock valued at $29,110,000 after purchasing an additional 246,393 shares during the last quarter. Loomis Sayles & Co. L P increased its holdings in shares of Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock valued at $27,727,000 after purchasing an additional 503,002 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Privia Health Group by 10.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock valued at $27,687,000 after purchasing an additional 138,747 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Privia Health Group by 14.2% in the fourth quarter. Northern Trust Corp now owns 1,392,641 shares of the company's stock valued at $27,226,000 after purchasing an additional 173,563 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 3,445 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $80,371.85. Following the completion of the sale, the chief financial officer owned 176,231 shares of the company's stock, valued at $4,111,469.23. This represents a 1.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Parth Mehrotra sold 15,100 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the sale, the chief executive officer directly owned 454,281 shares of the company's stock, valued at approximately $10,598,375.73. This represents a 3.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,949 shares of company stock valued at $1,100,368 in the last quarter. Insiders own 10.70% of the company's stock.

Analyst Ratings Changes

PRVA has been the subject of several recent analyst reports. Truist Financial upped their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Evercore ISI cut their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research report on Wednesday, July 9th. Barclays upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 27th. Robert W. Baird upped their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $28.38.

Privia Health Group Stock Down 5.3%

PRVA stock opened at $19.61 on Friday. The firm has a market capitalization of $2.39 billion, a PE ratio of 163.43, a PEG ratio of 3.14 and a beta of 0.82. Privia Health Group, Inc. has a twelve month low of $16.47 and a twelve month high of $26.09. The stock has a 50-day simple moving average of $22.54 and a two-hundred day simple moving average of $22.97.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.